Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 92.11 USD -0.56% Market Closed
Market Cap: 114.7B USD
Have any thoughts about
Gilead Sciences Inc?
Write Note

Gilead Sciences Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gilead Sciences Inc
Research & Development Peer Comparison

Comparables:
ABBV
AMGN
ALNY
VRTX
REGN

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Research & Development
-$5.5B
CAGR 3-Years
-4%
CAGR 5-Years
10%
CAGR 10-Years
-9%
Abbvie Inc
NYSE:ABBV
Research & Development
-$7.9B
CAGR 3-Years
-4%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Research & Development
-$5.8B
CAGR 3-Years
-7%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Research & Development
-$1.1B
CAGR 3-Years
-14%
CAGR 5-Years
-13%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Research & Development
-$3.5B
CAGR 3-Years
-7%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Research & Development
-$4.9B
CAGR 3-Years
-20%
CAGR 5-Years
-14%
CAGR 10-Years
-15%

See Also

What is Gilead Sciences Inc's Research & Development?
Research & Development
-5.5B USD

Based on the financial report for Sep 30, 2024, Gilead Sciences Inc's Research & Development amounts to -5.5B USD.

What is Gilead Sciences Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-9%

Over the last year, the Research & Development growth was 6%. The average annual Research & Development growth rates for Gilead Sciences Inc have been -4% over the past three years , 10% over the past five years , and -9% over the past ten years .

Back to Top